Skip to content

Clinical trials

Esophageal Neoplasms trials with no applicable phase and unknown status

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Esophageal Neoplasms Phase: Not applicable Status: Unknown status Clear all

92 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20021
20061
20071
20082
20092
20102
20112
20123
20144
20153
20165
20178
20186
20198
20209
20217
202216
20237
20245

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Unknown status92

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
National Taiwan University Hospital5
Michael Bau Mortensen3
Sun Yat-sen University3
Daping Hospital and the Research Institute of Surgery of the Third Military Medical University2
Instituto do Cancer do Estado de São Paulo2
RenJi Hospital2
Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine2
The First Affiliated Hospital of Henan University of Science and Technology2
Tianjin Medical University Cancer Institute and Hospital2
University Hospital Tuebingen2

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Esophageal Neoplasms92
Stomach Neoplasms18
Pancreatic Neoplasms9
Head and Neck Neoplasms6
Barrett Esophagus5
Anastomotic Leak4
Colorectal Neoplasms4
Lung Neoplasms4
Neoplasms4
Esophageal Diseases3

Trials

Showing 1 to 25 of 92. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.